Tag: GlobalData

Top 20 Global Biopharma Companies See 2% Growth

Top 20 Global Biopharma Companies See 2% Growth The biopharmaceutical industry demonstrated signs of recovery in the third quarter (Q3) of 2024, with increased investor optimism following the interest rate cuts by the US Federal Reserve in September 2024. As a result, the top 20 global biopharmaceutical companies reported an upturn of 2% in aggregate market capitalization from $4.2 trillion as on 30 June 2024...

Economy November 18, 2024

APAC deal volume dips 4.8% YoY

APAC deal volume dips 4.8% YoY A total of 11,808 deals (mergers & acquisitions (M&A), private equity and venture financing deals) were announced in the Asia-Pacific (APAC) region during January to October 2024, which was a year-on-year (YoY) decline of 4.8% compared to the 12,406 deals announced during the same period in 2023, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database revealed...

Business November 17, 2024

Tag: GlobalData

Top 20 Global Biopharma Companies See 2% Growth

APAC deal volume dips 4.8% YoY

High value deal volume decline reflects shift in investor strategies in 2023

US and China dominate global high value VC funding deals volume with 70% share in 2023

VC funding in India down by more than half to $7.8 billion in 2023

UK venture funding value down by 39.4% to $14.2 billion in 2023

North America companies dominate Forbes 2000 list with $19.3 trillion revenue in 2023

France set to be most visited country in the world by 2025

How much the Energy transition drove the 20 M&A deals in mining

Top 20 global biopharmaceutical companies report 9.1% QoQ decline

Why Construction growth will decrease?

VC funding by China startups soar 55.9% in August 2022

China continues to lead global e-commerce market with over $2 trillion sales in 2022

Qatar gas only short-term solution to Italy’s Russian imports problem